Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

OK
2019 Biennial Symposium

Scientific Program

 

The initial schedule for the 2019 IES Symposium is listed below.

IES Scientific Program                   

Tuesday 9 July

Welcome Reception (Portland Marriott Downtown Waterfront)

18:00 - 18:30 Welcome - Bruce Bochner, USA & Allison Fryer, USA

18:30 - 19:00 History of Eosinophil Discovery or Why Did Eosinophils Capture My Attention - Jerry Gleich, USA

18:30 - 21:00 Welcome Reception

                               

Wednesday 10 July

07:00 - 08:00 Breakfast with a Mentor Session: How to Navigate a Scientific Conference - Jackie Wirz, USA

Session 1: Eosinophils Across Species, What Does That Tell Us About Their Physiological Role, Evolution and Choice of Animal Models

08:00 - 08:30 Eosinophil Evolution Across Species - Steve Ackerman, USA

08:30 - 09:00 Eosinophils and Disease Models from Mouse to Man: We are Stronger Together - Helene Rosenberg, USA

09:00 - 09:30 Eosinophil Identity in the Tissue Contexts of Development, Homeostasis, and Disease - Sergejs Berdnikovs, USA

09:30 - 09:45 Oral Abstract #1

09:45 - 10:00 Oral Abstract #2

                               

10:00 - 10:30 Morning Break

        

Session 2: Eosinophil Life Cycle, Hematopoiesis and Recruitment, Activation and Death

10:30 - 11:00 Hemopoietic Mechanisms in Eosinophilic Inflammation - Roma Sehmi, Canada

11:00 - 11:30 Eosinophils in Liver Death - Todd Davidson, USA

11:30 - 12:00 Eosinophil ETosis and DNA Traps: a New Look at Eosinophilic Inflammation - Shigeharu Ueki, Japan

12:00 - 12:30 Eosinophil Shape Change and Granule Secretion - Paige Lacy, Canada

12:30 - 13:00 IES Business Meeting

                               

13:00 - 14:30 Lunch (on your own)

                       

14:30 - 15:30 Gleich Award Winner Lecture -
Eosinophil Depletion Suppresses Radiation-Induced Small Intestinal Fibrosis
- Naoki Takemura, Japan

15:30 - 16:00 Eosinophil Extracellular DNA Traps in Skin Diseases - Dagmar Simon, Switzerland

16:00 - 16:15 Oral Abstract #3

16:15 - 16:30 Oral Abstract #4

                               

17:00 - 19:00 Poster Session 1

                               

Thursday 11 July

07:00 - 08:00 Breakfast with a Mentor Session: How NIH Supports Clinical Trials - Lisa Wheatley, USA

07:00 - 08:00 Breakfast with a Mentor Session: Program Officers, Study Sections, RFA and PAs: Learn the language, protocols and best practices to interact with the NIH - Michael Minnicozzi, USA

Session 3: Eosinophils and Host Defense

08:00 - 08:30 Role of Eosinophils in VIRAL INFECTION - Amali Samarasinghe, USA

08:30 - 09:00 Eosinophils Suppress Th1 Responses and Restrict Bacterially Induced Gastrointestinal Inflammation - Isabela Arnold, Switzerland

09:00 - 09:30 Eosinophil Phenotypes in Immune Pathways - Elizabeth Jacobsen, USA

09:30 - 09:45 Oral Abstract #5

09:45 - 10:00 Oral Abstract #6

                               

10:00 - 10:30 Morning Break

                               

Session 4: Eosinophils and Nerves

10:30 - 11:00 Maternal Eosinophils Regulate Airway Nerve Development in Offspring - Katie Lebold, USA

11:00 - 11:30 Eosinophils Promote Sensory Nerve Growth in Human Asthma - Matthew Drake, USA

11:30 - 12:00 Eosinophils and Itch - David Jacoby, USA

12:00 - 12:15 Oral Abstract #7

12:15 - 12:30 Oral Abstract #8

                               

12:30 - 15:00 Lunch (on your own)

                               

15:00 - 16:00 Ehrlich Award Winner Lecture - Regulation and Control of Eosinophilia - Marc Rothenberg, USA

 

Session 5: Eosinophils and Metabolic Disease

16:00 - 16:30 Extreme IL-33-Dependent Eosinophil Accumulation in Adipose Tissue - Alyssa Hasty, USA

16:30 - 16:45 Oral Abstract #9

16:45 - 17:00 Oral Abstract #10

                               

17:00 - 19:00 Poster Session 2

                               

Friday 12 July

Session 6: Eosinophils in Chronic Inflammatory Disease - Asthma

08:00 - 08:30 ASTHMA - Autoimmune Responses, Eosinophils and Complex Airway Disease - Manali Mukherjee, Canada

08:30 - 09:00 ASTHMA - Anti IL5 Therapies for Severe Asthma: Targeting The Ligand vs The Receptor - Parameswaran Nair, Canada

09:00 - 09:30 LUNG - Targeting Eosinophils in Eosinophil Granulomatosis with Polyangitis - Michael E. Wechsler, USA

09:30 - 09:45 Oral Abstract #11

09:45 - 10:00 Oral Abstract #12

                               

10:00 - 10:30 Morning Break

                               

Session 7: Eosinophils in Chronic Inflammatory Disease- GI

10:30 - 11:00 ESOPHAGUS - Eosinophilic Esophagitis-like Disease:  Description of a New Disease Entity – Hans-Uwe Simon, Switzerland

11:00 - 11:30 GI OR SUBSETS - Phenotypically Distinct Subsets of Eosinophils Resident in Intestine - Lisa Spencer, USA

11:30 - 12:00 GI - Markers of Chronic Inflammatory Bowel Disease - Marie Carlson, Sweden

12:00 - 12:30 GI and SKIN - A Pathophysiological Potpourri of Conundrums and Challenges in Eosinophil-Related Epithelial Inflammation - Kristin Leiferman, USA

12:30 - 12:45 Oral Abstract #13

12:45 - 13:00 Oral Abstract #14

                               

13:00 - 14:30 Lunch (on your own)

13:00 - 14:30 CEGIR Lecture Session - "Findings from the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)"
(lunch available for purchase during registration)

 

    

Session 8: Eosinophils in Cancer                          

14:30 - 15:00 IL-33 Restricts Tumor Growth and Inhibits Pulmonary Metastasis in Melanoma-Bearing Mice Through Eosinophils - Giovanna Schiavoni, Italy

15:00 - 15:30 Activated Eosinophils Exert Distinct Anti-Tumorigenic Activities in Colorectal Cancer - Ariel Munitz, Israel

15:30 - 16:00 Charcot-Leyden Protein and antibody mediated resolution of Charcot-Leyden Crystals - Helena Aegerter, Beligum

16:00 - 16:15 Oral Abstract #15

16:15 - 16:30 Oral Abstract #16

                               

 

 

Saturday 13 July

Session 9: The Now and Future of Eosinophils as a Drug Target

08:00 - 08:30 “Siglec”ting the Allergic Response for Therapeutic Targeting - Bruce Bochner, USA

08:30 - 09:00 Developing Dexpramipexole for the Treatment of Hyper Eosinophillic Syndrome - Calman Prussin, USA

09:00 - 09:30 Subtypes of Responders to Mepolizumab in Hypereosinophilic Syndrome - Paneez Khoury, USA

09:30 - 10:00 Safety of Long Term Mepolizumab in HES - Amy Klion, USA

10:00 - 10:30 EOS, Exacerbations and Adherence…The Good, Bad and Ugly of Severe Asthma - Richard Costello, Ireland

10:30 - 10:45 Oral Abstract #17

                               

10:45 - 11:15 Morning Break

                               

11:15 - 12:15 Roundtable Discussion 1 - New Emerging or Controversial Topics - Is There More Than One Type of Eosinophil?

12:15 - 13:15  Roundtable Discussion 2 - New Emerging or Controversial Topics - Eosinophils-What are They Good For?

*Schedule Subject to Change